SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Kosan BioSciences -- KOSN
An SI Board Since May 2001
Posts SubjectMarks Bans Symbol
933 40 0 KOSN
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
133Another question for IR might be, why no mention of manufacturing responsibilitykeokalani'nui-9/24/2002
132<i>13- and 15-desmethoxy analogs of FK520</i> Guilford Pharmaceuticscaram(o)uche-9/24/2002
131<<I like the buy-in, but to have to do it in advance of a bigass P3 will brkrw-9/23/2002
130Wildest, Closest query to a burn-related issue was the question as to "amoquidditch-9/23/2002
129<i>I'm guessing 15%.</i> My guess (before seeing Rick's resBiomaven-9/23/2002
128Quid-- Thanks very much. Any mention of revised burn in '02/'03? Surpkeokalani'nui-9/23/2002
127Could it be an angle to make them less attractive to Novartis? Duplication of escaram(o)uche-9/23/2002
126Nice deal. Clearly shows serious, substantial interest in epo-d. And $30m will keokalani'nui-9/23/2002
125sorry, was playing school bus. I'm guessing 15%.scaram(o)uche-9/23/2002
124<i>Let's hope that by the time Roche actually has to pay royalties on quidditch-9/23/2002
123>> Still expecting news from the antibiotic front. << embargo in efscaram(o)uche-9/23/2002
122Even better than my guess. That Roche is the partner is a surprise; I sort of etuck-9/23/2002
121Roche and Kosan to Jointly Develop and Commercialise Kosan's Epothilone D Asscaram(o)uche-9/23/2002
120a couple of newer publications...... LAULIMALIDE DERIVATIVES Patent Number: scaram(o)uche-9/21/2002
119random picks with a mix of news...... siliconinvestor.com looks pretty good! scaram(o)uche-9/21/2002
118Not sure I'm making any weekend bet on the come, given the chart.keokalani'nui-9/21/2002
117My bet is a successful conclusion of the pilot study mentioned a few posts ago: tuck-9/21/2002
116taking bets.......scaram(o)uche-9/20/2002
115Kosan Conference Call Scheduled to start Mon, Sep 23, 2002, 9:00 am Eastern bizkeokalani'nui-9/20/2002
114Chuckle. My kids, with dad's attention span, call that sort of stuff "scaram(o)uche-8/29/2002
113<i>You hang on my every word, correct?.......</i> I do, as might bekeokalani'nui-8/29/2002
112Not that I understand all the potential pharmaceutical implications of the polykquidditch-8/29/2002
111You hang on my every word, correct?....... Message 17919835 :-)scaram(o)uche-8/29/2002
110Oh goodie. J Pharmacol Exp Ther 2002 Sep;302(3):1278-85 Related Articles, Bookskeokalani'nui-8/29/2002
109It's certainly worth bouncing off of them.scaram(o)uche-8/27/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News